Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
170M
-
Number of holders
-
204
-
Total 13F shares, excl. options
-
148M
-
Shares change
-
+793K
-
Total reported value, excl. options
-
$2.42B
-
Value change
-
+$23.5M
-
Put/Call ratio
-
0.73
-
Number of buys
-
94
-
Number of sells
-
-102
-
Price
-
$16.36
Significant Holders of ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD) as of Q3 2022
272 filings reported holding ACAD - ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value as of Q3 2022.
ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD) has 204 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 148M shares
of 170M outstanding shares and own 87.07% of the company stock.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (41.9M shares), VANGUARD GROUP INC (12.9M shares), FMR LLC (11.6M shares), BlackRock Inc. (9.97M shares), STATE STREET CORP (6.78M shares), EcoR1 Capital, LLC (5.99M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.89M shares), D. E. Shaw & Co., Inc. (4.71M shares), RTW INVESTMENTS, LP (3.67M shares), and FIRST TRUST ADVISORS LP (2.92M shares).
This table shows the top 204 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.